Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study

Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study

BackgroundSarcoma is a highly heterogeneous malignancy with a poor prognosis. Although chemotherapy and targeted therapy have improved the prognosis to some extent, the efficacy remains unsatisfactory in some patients. The efficacy and safety of immunotherapy in sarcoma need further evaluation.Metho...

Full description

Bibliographic Details
Main Authors: Zhichao Liao, Jianjin Teng, Tao Li, Haotian Liu, Ting Li, Chao Zhang, Ruwei Xing, Sheng Teng, Yun Yang, Jun Zhao, Wanyi Xiao, Gengpu Zhang, Mulin Jun Li, Weitao Yao, Jilong Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Immunology
Subjects:
sarcoma
immunotherapy
efficacy
adverse event
two-center
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1292325/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1292325/full

Similar Items